Command Palette

Search for a command to run...

NEULANDLAB

1301839 (0.3%)

Quarterly ResultsProfit & LossBalance SheetCash Flow

Key Insights

POSITIVE
  • Net profit margin surged to 8.47% in Q1 202503 from 23.76% in Q4 202406, reflecting operational challenges in Q1.
  • Operating margin improved compared to Q4 202412, showing a potential recovery trend toward stability in operations.
  • Other income increased slightly in Q1 202503, suggesting diversification of revenue streams.
NEGATIVE
  • Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
  • Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
  • Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
FieldTrendSep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25
Revenue
417.75392.83385.01439.60310.84398.03328.36292.75
Expenses
299.20290.45298.17335.19265.75329.95296.52283.04
Operating Profit
118.55102.3886.84104.4145.0968.0831.839.72
Other Income
3.052.105.364.814.333.917.467.86
Interest
4.433.743.612.671.062.222.354.58
Depreciation
14.5115.1416.4616.2816.0716.3016.8920.19
Profit Before Tax
121.59104.4892.20129.8449.42127.7639.3017.57
Tax
32.3523.0924.6431.9716.5826.1811.493.67
Net Profit
89.2581.3967.5697.8732.84101.5927.8113.90
EPS in Rs
69.5663.4452.6676.2825.6079.1821.6710.83